Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Accounts Payables (2010 - 2026)

Innoviva's (INVA) quarterly Accounts Payables came in at $6.5 million in Q1 2026, up 38.68% YoY from $4.7 million in Q1 2025, and up 31.25% on a QoQ basis from $5.0 million in Q4 2025.

Analysis

Innoviva (INVA) Accounts Payables (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Accounts Payables data on file, last reported at $6.5 million in Q1 2026.

  • Quarterly Accounts Payables rose 38.68% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 38.68% YoY) and the FY2025 annual result came in at $5.0 million, up 132.93% from the prior year.
  • Accounts Payables grew to $6.5 million in Q1 2026, from $5.0 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $6.7 million in Q4 2023 to a low of $890000.0 in Q1 2024.
  • A 5-year average of $4.2 million and a median of $4.3 million in 2022 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2022 — Accounts Payables surged 14310.0% — and 2024, when it plunged 85.0%.
  • Tracing INVA's Accounts Payables over 5 years: stood at $2.9 million in 2022, then surged by 128.55% to $6.7 million in 2023, then sank by 68.26% to $2.1 million in 2024, then soared by 132.93% to $5.0 million in 2025, then soared by 31.25% to $6.5 million in 2026.
  • The last three Accounts Payables figures came in at $6.5 million (Q1 2026), $5.0 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn 4.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.02 Mn
Mar 31, 2026 6.52 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 6.24 Mn
Jun 30, 2025 5.38 Mn
Mar 31, 2025 4.70 Mn
Dec 31, 2024 2.13 Mn
Sep 30, 2024 4.17 Mn
Jun 30, 2024 2.04 Mn
Mar 31, 2024 890,000.00
Dec 31, 2023 6.72 Mn
Sep 30, 2023 3.78 Mn
Jun 30, 2023 4.59 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 3.81 Mn
Jun 30, 2022 4.32 Mn
Mar 31, 2022 1.81 Mn
Dec 31, 2021 27,000.00
Sep 30, 2021 89,000.00